VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
---|---|---|---|---|---|---|---|---|
TVIS30014605 | HIV | ENSG00000174175.17 | protein_coding | SELP | No | No | 6403 | P16109 Q5R341 Q6NUL9 |
TVIS20029044 | HPV | ENSG00000174175.17 | protein_coding | SELP | No | No | 6403 | P16109 Q5R341 Q6NUL9 |
TVIS20048087 | HPV | ENSG00000174175.17 | protein_coding | SELP | No | No | 6403 | P16109 Q5R341 Q6NUL9 |
TVIS20068815 | HPV | ENSG00000174175.17 | protein_coding | SELP | No | No | 6403 | P16109 Q5R341 Q6NUL9 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
Gene | SELP |
---|---|
DrugBank ID | DB08813 |
Drug Name | Nadroparin |
Target ID | BE0001159 |
UniProt ID | P16109 |
Regulation Type | inhibitor |
PubMed IDs | 17629851; 16525583 |
Citations | Simonis D, Christ K, Alban S, Bendas G: Affinity and kinetics of different heparins binding to P- and L-selectin. Semin Thromb Hemost. 2007 Jul;33(5):534-9.@@Ludwig RJ, Alban S, Bistrian R, Boehncke WH, Kaufmann R, Henschler R, Gille J: The ability of different forms of heparins to suppress P-selectin function in vitro correlates to their inhibitory capacity on bloodborne metastasis in vivo. Thromb Haemost. 2006 Mar;95(3):535-40. |
Groups | Approved; Investigational |
Direct Classification | |
SMILES | |
Pathways | |
PharmGKB | |
ChEMBL |